OR WAIT null SECS
- About Us
- Advertise
- Editorial Information
- Contact Us
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2024 MJH Life Sciences™ and BioPharm International. All rights reserved.
Video: Risk Management of Adventitious Agent Contamination in Biopharmaceutical Products
During this podcast, we will discuss the causes and implications of Adventitious Agent Contamination for pharmaceutical and biopharmaceutical manufacturers. We will discuss ways in which Lancaster Laboratories is helping manufacturers minimize the risk for this contamination to avoid production delays.
During this podcast, we will discuss the causes and implications of Adventitious Agent Contamination for pharmaceutical and biopharmaceutical manufacturers. We will discuss ways in which Lancaster Laboratories is helping manufacturers minimize the risk for this contamination to avoid production delays.
Presenter:
Jeri Ann Boose, Ph.D.
Director, Biopharmaceutical Services
Lancaster Laboratories
Katherine Bergmann, Ph.D.
Manager, Viral Safety and Viral Clearance Services
Lancaster Laboratories
Online Resources:
Register for the Live Web Conference More Information
